본문 바로가기
KERD
논문KCI 등재

Reply: Comments on the Published Meta-Analysis of Clinical and Microbiologic Efficacy and Safety of Imipenem/Cilastatin/Relebactam in Complicated Infections

1

조회

0

다운로드

0

인용

0

참고문헌

주제분류내과학

참고문헌 (1)

  1. Syeda Sahra, "Clinical and Microbiologic Efficacy and Safety of Imipenem", Cilastatin, Infection and Chemotherapy, pp.2021, 53(2)[DOI]

관련 논문AI추천

Comments on the Published Meta-Analysis of Clinical and Microbiologic Efficacy and Safety of Imipenem/Cilastatin/Relebactam in Complicated InfectionsJafarzadeh Fatemeh, Mohammadi Amirhossein, Vaziri Ali Zaman대한감염학회 · Infection and Chemotherapy2021 · 제53권 제3호Clinical and Microbiologic Efficacy and Safety of Imipenem/Cilastatin/Relebactam in Complicated Infections: A Meta-analysisAbdullah Jahangir, Ahmad Jahangir, Allison Glaser, Rachelle Hamadi, Syeda Sahra대한감염학회 · Infection and Chemotherapy2021 · 제53권 제2호Reply: The Efficacy of Penicillins with β-lactamase Inhibitor or Cefmetazole against Pneumonia in which ESBL-Producing Bacteria were Isolated from SputumKang Cheol-In대한감염학회 · Infection and Chemotherapy2021 · 제53권 제3호Comparison of Efficacy of Cefoperazone/Sulbactam and Imipenem/Cilastatin for Treatment of Acinetobacter Bacteremia김명수, 김연아, 김영근, 김준명, 김창오, 박윤선, 송영구, 신소연, 용동은, 윤희정, 이경원, 최준용연세대학교의과대학 · Yonsei Medical Journal2006 · 제47권 제1호Reply: Antimicrobial Stewardship at the End of Life: From Overtreatment to Responsible PracticeAlwazzeh Marwan Jabr대한감염학회 · Infection and Chemotherapy2025 · 제57권 제4호Reply: Response to Nationwide Analysis of Antimicrobial Prescription in Korean Hospitals between 2018 and 2021: The 2023 KONAS ReportChae Jungmi, Choi Jun Yong, Kim Bongyoung, Kim Yong Chan, Park Hyo Jung, Yun I Ji대한감염학회 · Infection and Chemotherapy2024 · 제56권 제4호

이 간행물의 다른 논문 (24건)